Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of dihydroisoindolo[2,1-<i>a</i>]quinolin-11-ones, their <i>in silico</i> ADMET properties and <i>in vitro</i> antitumor activities.

RSC advances·2022
Same author

Anticancer potential of new 3-nitroaryl-6-(N-methyl)piperazin-1,2,4-triazolo[3,4-a]phthalazines targeting voltage-gated K<sup>+</sup> channel: Copper-catalyzed one-pot synthesis from 4-chloro-1-phthalazinyl-arylhydrazones.

Bioorganic chemistry·2020
Same author

Anti-leishmanial effect of spiro dihydroquinoline-oxindoles on volume regulation decrease and sterol biosynthesis of Leishmania braziliensis.

Experimental parasitology·2019
Same author

Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel.

Chemical biology & drug design·2018
Same author

In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.

Acta tropica·2018
Same author

Cancer and the metastatic substrate.

Ecancermedicalscience·2017

Related Experiment Video

Updated: May 8, 2026

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
09:16

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor

Published on: June 14, 2018

[Micrometastases: strategies for detection].

Francisco Arvelo1

  • 1Centro de Biociencias, Fundación IDEA. Carretera Nacional Hoyo de la Puerta, Valle de Sartanejas, Baruta, Edo. Miranda, Venezuela. franarvelo@yahoo.com

Investigacion Clinica
|August 17, 2013
PubMed
Summary
This summary is machine-generated.

Detecting micrometastasis or minimal residual disease is crucial in oncology. New diagnostic methods help identify these tiny tumors to personalize cancer treatment and prevent recurrence.

More Related Videos

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Experiment Videos

Last Updated: May 8, 2026

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
09:16

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor

Published on: June 14, 2018

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
05:17

Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment

Published on: May 14, 2019

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Area of Science:

  • Oncology
  • Cancer Biology
  • Diagnostic Pathology

Context:

  • Micrometastasis and minimal residual disease pose significant challenges in cancer care.
  • The clinical response of these microscopic tumor foci to existing treatments remains largely unknown.
  • Accurate detection is vital for effective cancer management.

Purpose:

  • To review and evaluate novel diagnostic methods for identifying micrometastasis and minimal residual disease.
  • To explore techniques that enable precise location and quantification of these small tumor cell populations.
  • To assess advancements in diagnostic tools for residual cancer detection.

Summary:

  • Current immunohistochemical and molecular biology techniques allow for the detection of tumor cell microfoci in various tissues.
  • Advanced methods like flow cytometry and sophisticated molecular assays are available for quantifying these lesions.
  • This review focuses on the evaluation of emerging diagnostic strategies for residual disease.

Impact:

  • Enabling the identification of minimal residual disease can lead to individualized cancer treatment strategies.
  • Improved detection methods can help prevent disease recurrence in cancer patients.
  • Advances in diagnostics are key to overcoming the challenges posed by micrometastasis.